Free Trial

ZIVO Bioscience (ZIVO) Competitors

ZIVO Bioscience logo
$15.71 -2.29 (-12.72%)
As of 11:37 AM Eastern

ZIVO vs. RNAC, TSVT, ALMS, INZY, GLUE, TERN, PVLA, LFCR, TNGX, and GOSS

Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Cartesian Therapeutics (RNAC), 2seventy bio (TSVT), Alumis (ALMS), Inozyme Pharma (INZY), Monte Rosa Therapeutics (GLUE), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR), Tango Therapeutics (TNGX), and Gossamer Bio (GOSS). These companies are all part of the "pharmaceutical products" industry.

ZIVO Bioscience vs.

Cartesian Therapeutics (NASDAQ:RNAC) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends.

Cartesian Therapeutics currently has a consensus price target of $43.00, indicating a potential upside of 390.31%. Given Cartesian Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Cartesian Therapeutics is more favorable than ZIVO Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cartesian Therapeutics
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
ZIVO Bioscience
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

ZIVO Bioscience has a net margin of 0.00% compared to Cartesian Therapeutics' net margin of -510.72%.

Company Net Margins Return on Equity Return on Assets
Cartesian Therapeutics-510.72% N/A -6.03%
ZIVO Bioscience N/A N/A -2,240.92%

86.9% of Cartesian Therapeutics shares are held by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are held by institutional investors. 57.9% of Cartesian Therapeutics shares are held by insiders. Comparatively, 21.5% of ZIVO Bioscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ZIVO Bioscience has lower revenue, but higher earnings than Cartesian Therapeutics. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Cartesian Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cartesian Therapeutics$34.17M6.66-$219.71M-$52.83-0.17
ZIVO Bioscience$15.85K4,330.22-$7.78M-$4.93-3.65

In the previous week, Cartesian Therapeutics had 11 more articles in the media than ZIVO Bioscience. MarketBeat recorded 11 mentions for Cartesian Therapeutics and 0 mentions for ZIVO Bioscience. Cartesian Therapeutics' average media sentiment score of 0.69 beat ZIVO Bioscience's score of 0.00 indicating that Cartesian Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Cartesian Therapeutics Positive
ZIVO Bioscience Neutral

Cartesian Therapeutics has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500.

ZIVO Bioscience received 60 more outperform votes than Cartesian Therapeutics when rated by MarketBeat users. However, 95.12% of users gave Cartesian Therapeutics an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote.

CompanyUnderperformOutperform
Cartesian TherapeuticsOutperform Votes
39
95.12%
Underperform Votes
2
4.88%
ZIVO BioscienceOutperform Votes
99
60.74%
Underperform Votes
64
39.26%

Summary

Cartesian Therapeutics beats ZIVO Bioscience on 12 of the 17 factors compared between the two stocks.

Get ZIVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIVO vs. The Competition

MetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$68.64M$2.96B$5.38B$8.46B
Dividend YieldN/A1.64%5.28%4.17%
P/E Ratio-3.6931.7227.0319.89
Price / Sales4,330.22416.79403.36138.33
Price / CashN/A168.6838.2534.64
Price / Book-22.223.226.774.56
Net Income-$7.78M-$72.35M$3.22B$248.06M
7 Day PerformanceN/A2.25%1.71%2.14%
1 Month Performance-4.27%1.52%6.97%9.07%
1 Year Performance125.56%-21.70%19.51%9.74%

ZIVO Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIVO
ZIVO Bioscience
N/A$15.71
-12.7%
N/A+125.6%$59.90M$15,850.00-3.2210Gap Up
RNAC
Cartesian Therapeutics
1.6468 of 5 stars
$10.37
+1.1%
$42.50
+309.8%
-64.3%$269.14M$34.17M-0.2064
TSVT
2seventy bio
1.1496 of 5 stars
$5.00
flat
$4.25
-15.0%
N/A$266.15M$48.37M-2.69440
ALMS
Alumis
2.286 of 5 stars
$5.95
+5.9%
$24.86
+317.8%
N/A$265.38MN/A0.00N/AAnalyst Revision
INZY
Inozyme Pharma
3.1922 of 5 stars
$3.99
+1.0%
$11.75
+194.5%
-13.6%$257.60MN/A-2.5650Positive News
High Trading Volume
GLUE
Monte Rosa Therapeutics
1.8839 of 5 stars
$4.11
+3.3%
$15.50
+277.1%
-4.1%$252.81M$159.49M-2.2590Positive News
TERN
Terns Pharmaceuticals
4.218 of 5 stars
$3.15
+9.4%
$15.63
+396.0%
-49.8%$251.53MN/A-2.6740Positive News
PVLA
Palvella Therapeutics
3.8462 of 5 stars
$22.56
+2.3%
$46.29
+105.2%
N/A$249.13M$42.81M-1.86N/A
LFCR
Lifecore Biomedical
1.1881 of 5 stars
$6.71
-2.6%
$8.00
+19.2%
+24.6%$248.44M$130.31M-11.98690
TNGX
Tango Therapeutics
1.7627 of 5 stars
$2.29
+52.7%
$12.33
+438.6%
-70.3%$248.22M$40.99M-1.9490Gap Down
High Trading Volume
GOSS
Gossamer Bio
3.8593 of 5 stars
$1.09
+4.8%
$7.75
+611.0%
+80.7%$247.67M$114.70M-3.41180Analyst Revision

Related Companies and Tools


This page (NASDAQ:ZIVO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners